Dr. Birte Wistinghausen, MD

  • Washington, DC
  • Pediatric hematology and oncology physician
NPI1043314784
Publications
27
Clinical trials
10
Hospital affiliations
1
Industry payments
$108
Medical group
1
Practice address
111 Michigan Ave, NW, Washington, DC 20010
Practice phone
Call (202) 476-5000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Children's National Hospital

Hospital · Washington, District of Columbia

See all 3 affiliations

Find Dr. Wistinghausen's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Birte Wistinghausen is a pediatric hematology and oncology physician in Washington, District of Columbia

Dr. Wistinghausen practices at Children's National Hospital in Washington, District of Columbia, part of Children's National Hospital.

Dr. Wistinghausen's NPI, 1043314784, was assigned on September 12, 2006. Dr. Wistinghausen holds New York license 215640.

NPI and contact details
NPI enumeration date
September 12, 2006
NPI status
Active
Practice phone
(202) 476-5000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data

Dr. Birte Wistinghausen practices at Children's National Hospital in Washington, District of Columbia

Dr. Wistinghausen's primary practice is Children's National Hospital, at 111 Michigan Ave, NW, Washington, DC 20010 in The District County. The practice phone is (202) 476-5000.

Source: Dmand AI Affiliation Data

Dr. Birte Wistinghausen is affiliated with 2 sites of care and 1 medical group

Dr. Wistinghausen's primary practice is Children's National Hospital in Washington, District of Columbia, part of Children's National Hospital. The medical group on file is Children's National Hospital. Dmand AI also links Dr. Wistinghausen to 1 more dialysis center, named with a free account.

See all 3 affiliations for Dr. Wistinghausen

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Birte Wistinghausen's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wistinghausen practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Children's National HospitalAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Wistinghausen practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Children's National Hospital and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Birte Wistinghausen is one of 65 pediatric hematologys and oncology physicians in District of Columbia

Pediatric hematology-oncology is Dr. Wistinghausen's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Wistinghausen is licensed in New York.

Specialties and state licenses

  • Pediatric hematology and oncology, New YorkPrimaryLicense 215640 · taxonomy 2080P0207X

Pediatric hematologys and oncology physicians near Dr. Wistinghausen

Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Birte Wistinghausen's patients have a median age of 10

Across all payers, Dmand AI patient panel data puts Dr. Wistinghausen's median patient age at 10, with 49% women.

Dr. Wistinghausen's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 10

Patient panel by sex, all payers

  • Women49%
  • Men51%

Source: Dmand AI Patient Panel Data

Dr. Birte Wistinghausen has 27 publications on record

Dmand AI links 27 papers to Dr. Wistinghausen, published from 2010 to 2024. 2024 was the busiest year, with 8. The most frequent topics are Epstein-Barr Virus Infections, Lymphoproliferative Disorders and Herpesvirus 4, Human. Dr. Wistinghausen has published most often in Pediatr Blood Cancer. Dr. Wistinghausen's most frequent co-authors are Michelle L. Hermiston, MD, Keri Toner, MD and Carl E. Allen, MD.

Papers27
Years published2010 to 2024

Dr. Wistinghausen's papers by year, 2011 to 2024

Topics Dr. Wistinghausen writes about most

  • Epstein-Barr Virus Infections
  • Lymphoproliferative Disorders
  • Herpesvirus 4, Human
  • Hematopoietic Stem Cell Transplantation
  • Organ Transplantation
  • Postoperative Complications
  • Histiocytosis, Langerhans-Cell
  • Immunosuppression Therapy

Dr. Wistinghausen's most frequent co-authors

Recent publications by Dr. Wistinghausen

See all 27 publications and co-authors

See who Dr. Wistinghausen researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Wistinghausen works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Birte Wistinghausen has worked on 10 clinical trials

Dmand AI links Dr. Wistinghausen to 10 clinical trials, 7 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Ganglioneuroblastoma, Neuroblastoma and Angiolipoma. National Cancer Institute (NCI) sponsors the most, 6.

Clinical trials with Dr. Wistinghausen by phase

  1. NonePhase 1: no trials
  2. NonePhase 2: no trials
  3. 1Phase 2/3: 1 trial
  4. 7Phase 3: 7 trials
  5. NonePhase 4: no trials

Conditions in Dr. Wistinghausen's trials

  • Ganglioneuroblastoma
  • Neuroblastoma
  • Angiolipoma
  • Burkitt Lymphoma
  • Chondrosarcoma, Mesenchymal

Investigators on the most trials with Dr. Wistinghausen

Recent clinical trials with Dr. Wistinghausen

See all 10 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Birte Wistinghausen received $108 in industry payments in 2020

CMS Open Payments shows 1 general payment to Dr. Wistinghausen from 1 drug or device company in 2020. Entertainment make up the largest share, 100% of the total. Eurofins Viracor, LLC paid the most, $108.

Companies that paid Dr. Wistinghausen the most, 2020 to 2020

Share is of all general payments to this clinician.

See all payments to Dr. Wistinghausen

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Birte Wistinghausen's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Birte Wistinghausen

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Birte Wistinghausen's NPI number?

Dr. Birte Wistinghausen's NPI number is 1043314784. It was assigned on September 12, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Birte Wistinghausen?

Dr. Birte Wistinghausen is a pediatric hematology and oncology physician in Washington, District of Columbia. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).

Where does Dr. Birte Wistinghausen practice?

Dr. Wistinghausen practices at 111 Michigan Ave, NW, Washington, DC 20010. Dr. Wistinghausen's primary practice is Children's National Hospital in Washington, District of Columbia, part of Children's National Hospital. Dmand AI also links Dr. Wistinghausen to 1 dialysis center.

What is Dr. Birte Wistinghausen's office phone number?

The practice phone on file for Dr. Wistinghausen is (202) 476-5000.

What is Dr. Birte Wistinghausen's medical license number?

Dr. Wistinghausen holds New York license 215640.

Which hospitals is Dr. Birte Wistinghausen affiliated with?

Dr. Wistinghausen practices at Children's National Hospital in Washington, District of Columbia.

What medical group is Dr. Birte Wistinghausen part of?

Dr. Wistinghausen is linked to Children's National Hospital.

Has Dr. Birte Wistinghausen received payments from drug or device companies?

CMS Open Payments shows $108 in general payments to Dr. Wistinghausen from 1 company from 2020 to 2020. The largest total came from Eurofins Viracor, LLC.

How long has Dr. Birte Wistinghausen been practicing?

Dr. Wistinghausen's NPI was assigned in 2006.

Does Dr. Birte Wistinghausen do research?

Dmand AI links 27 publications to Dr. Wistinghausen, published from 2010 to 2024. Dr. Wistinghausen has worked on 10 clinical trials.

Who does Dr. Birte Wistinghausen publish with?

Dr. Wistinghausen's most frequent co-authors are Michelle L. Hermiston, MD (5 shared papers), Keri Toner, MD (5 shared papers) and Carl E. Allen, MD (4 shared papers).

Selling to pediatric hematology-oncology practices?

See pediatric hematologys and oncology physicians in District of Columbia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)